Sun Pharma shares dipped in the intraday trading session on Friday, March 28. The Indian equity markets are in a tight spot, ...

Sun Pharmaceutical Industries Ltd. closed 11.68% below its 52-week high of 1,960.20 rupees, which the company reached on September 30th.

Indian pharma stocks fell for the third consecutive session amid concerns of potential US tariffs on pharmaceutical imports. The Nifty Pharma Index dropped 1.5%, with J B Chemicals & Pharmaceuticals ...

Sun Pharmaceutical Industries Ltd. closed 10.33% short of its 52-week high of 1,960.20 rupees, which the company reached on ...

Spooked by US president's threat, several Indian pharma players lobby for blanket duty waiver on drugs coming from America, ...

Homegrown pharmaceutical companies launching significantly cheaper generic versions of empagliflozin—a widely prescribed ...

Glenmark Pharmaceuticals Ltd. on Wednesday announced ... and Glempa-M (Empagliflozin 12.5 mg + Metformin 500/1000 mg). On Tuesday, Boehringer Ingelheim’s Empagliflozin became off-patent in ...

The stock of the country’s largest pharmaceutical company, Sun Pharmaceutical Industries (Sun Pharma), has shed about 15 per cent from its highs over the last three months. Weak US sales trajectory, ...

Checkpoint Therapeutics is being acquired by Sun Pharmaceutical for $4.10 per share. Learn why CKPT stockholders could earn an additional $0.7 with the CVR.

On Sunday, India-based Sun Pharmaceutical Industries Limited agreed to acquire U.S.-based immunotherapy and targeted oncology company Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) for an upfront ...

India's pharma giant Sun Pharma to acquire Checkpoint Therapeutics (NASDAQ:CKPT)—an immunotherapy and targeted oncology company—for an upfront cash payment of $355M. The deal involves an ...